These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35332224)

  • 1. Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis.
    Palumbo P; Ruscitti P; Cannizzaro E; Berardicurti O; Conforti A; Di Cesare A; Di Cola I; Giacomelli R; Splendiani A; Barile A; Masciocchi C; Cipriani P; Di Cesare E
    Sci Rep; 2022 Mar; 12(1):5125. PubMed ID: 35332224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study.
    Terrier B; Dechartres A; Gouya H; Ben Arfi M; Bérézne A; Régent A; Dunogué B; London J; Cohen P; Guillevin L; Le Jeunne C; Legmann P; Vignaux O; Mouthon L
    Arthritis Rheumatol; 2020 Sep; 72(9):1571-1580. PubMed ID: 32379399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.
    Poindron V; Chatelus E; Canuet M; Gottenberg JE; Arnaud L; Gangi A; Gavand PE; Guffroy A; Korganow AS; Germain P; Sibilia J; El Ghannudi S; Martin T
    Semin Arthritis Rheum; 2020 Feb; 50(1):128-134. PubMed ID: 31301817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.
    Tipparot T; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Pussadhamma B; Chaosuwannakit N
    Int J Rheum Dis; 2019 Dec; 22(12):2125-2133. PubMed ID: 31659856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
    Rodríguez-Reyna TS; Rosales-Uvera SG; Kimura-Hayama E; Hernández-Reyes P; Mercado-Velázquez P; Benavides-Suárez SA; Esquinca-González A; Núñez-Álvarez CA
    Semin Arthritis Rheum; 2019 Oct; 49(2):273-278. PubMed ID: 30853116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging.
    De Luca G; Bombace S; Monti L
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):343-357. PubMed ID: 35072931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters.
    Hromádka M; Seidlerová J; Suchý D; Rajdl D; Lhotský J; Ludvík J; Rokyta R; Baxa J
    Int J Cardiol; 2017 Dec; 249():448-453. PubMed ID: 28935460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Gadolinium Enhancement in Cardiac Magnetic Resonance Imaging Is Associated with High Renal Resistive Index in Patients with Systemic Sclerosis.
    Cianci R; Gigante A; Gasperini ML; Barbano B; Galea N; Rosato E
    Kidney Blood Press Res; 2020; 45(2):350-356. PubMed ID: 32101875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset.
    Giacomelli R; Di Cesare E; Cipriani P; Ruscitti P; Di Sibio A; Liakouli V; Gennarelli A; Carubbi F; Splendiani A; Berardicurti O; Di Benedetto P; Ciccia F; Guggino G; Radchenko G; Triolo G; Masciocchi C
    Int J Rheum Dis; 2017 Sep; 20(9):1247-1260. PubMed ID: 28580766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications.
    Bratis K; Lindholm A; Hesselstrand R; Arheden H; Karabela G; Stavropoulos E; Katsifis G; Kolovou G; Kitas GD; Sfikakis PP; Koutsogeorgopoulou L; Mavrogeni S; Ostenfeld E
    PLoS One; 2019; 14(8):e0221021. PubMed ID: 31433819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in cardiac magnetic resonance imaging in systemic sclerosis.
    Agoston-Coldea L; Zlibut A; Revnic R; Florea M; Muntean L
    Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3718-3736. PubMed ID: 34109581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test.
    Galea N; Rosato E; Gigante A; Borrazzo C; Fiorelli A; Barchetti G; Trombetta AC; Digiulio MA; Francone M; Catalano C; Carbone I
    PLoS One; 2020; 15(12):e0244282. PubMed ID: 33351821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".
    Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M
    Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
    Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.
    Lee DC; Hinchcliff ME; Sarnari R; Stark MM; Lee J; Koloms K; Hoffmann A; Carns M; Thakrar A; Aren K; Varga J; Aquino A; Carr JC; Benefield BC; Shah SJ
    J Scleroderma Relat Disord; 2018 Jun; 3(2):159-169. PubMed ID: 29808171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
    Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical progression of systemic sclerosis-related cardiomyopathy.
    Stronati G; Manfredi L; Ferrarini A; Zuliani L; Fogante M; Schicchi N; Capucci A; Giovagnoni A; Russo AD; Gabrielli A; Guerra F
    Eur J Prev Cardiol; 2020 Nov; 27(17):1876-1886. PubMed ID: 32306757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.
    Pieroni M; De Santis M; Zizzo G; Bosello S; Smaldone C; Campioni M; De Luca G; Laria A; Meduri A; Bellocci F; Bonomo L; Crea F; Ferraccioli G
    Semin Arthritis Rheum; 2014 Feb; 43(4):526-35. PubMed ID: 23932313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.